Literature DB >> 22337349

Cerebral mechanisms of experimental hyperalgesia in fibromyalgia.

M Burgmer1, B Pfleiderer, C Maihöfner, M Gaubitz, E Wessolleck, G Heuft, E Pogatzki-Zahn.   

Abstract

The present study examined the hyperresponsiveness of the central nervous system in patients with fibromyalgia syndrome (FMS) related to mechanical hyperalgesia. The goals were to differentiate between increased pain ratings and hyperalgesia related either to peripheral or to central sensitization and to correlate with cerebral activation pattern. Seventeen patients and 17 healthy controls were examined, placing an experimental incision in the right volar forearm and causing tonic pain. Experimental pain, primary and secondary hyperalgesia were assessed during the time course of the experimental pain, and the changes in hyperalgesia were correlated to brain activation (functional magnetic resonance imaging). Patients with FMS experienced the experimental pain during the time course as more painful than healthy controls (F(score)  = 3.93, p(score)  = 0.008). While they did not present a different course of primary hyperalgesia (F(score)  = 1.01, p(score)  = 0.40), they did show greater secondary hyperalgesia (F(score)  = 5.45, p(score)  = 0.004). In patients with FMS, the cerebral pattern corresponding to secondary hyperalgesia was altered. The activity in the dorsolateral prefrontal cortex was inversely correlated with secondary hyperalgesia in healthy controls (R = -0.34 p = 0.005); in patients, this correlation was disrupted (R = 0.19 p = 0.12). These findings point to an alteration of pain transmission at the central level in FMS (e.g., loss of inhibition) and might be related to changes in cerebral-midbrain-spinal mechanisms of pain inhibition.
© 2011 European Federation of International Association for the Study of Pain Chapters.

Entities:  

Mesh:

Year:  2011        PMID: 22337349     DOI: 10.1002/j.1532-2149.2011.00058.x

Source DB:  PubMed          Journal:  Eur J Pain        ISSN: 1090-3801            Impact factor:   3.931


  15 in total

1.  Decreased olfactory bulb volumes in patients with fibromyalgia syndrome.

Authors:  Selçuk Sayılır; Neşat Çullu
Journal:  Clin Rheumatol       Date:  2017-07-26       Impact factor: 2.980

Review 2.  Sex-based differences in brain alterations across chronic pain conditions.

Authors:  Arpana Gupta; Emeran A Mayer; Connor Fling; Jennifer S Labus; Bruce D Naliboff; Jui-Yang Hong; Lisa A Kilpatrick
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

Review 3.  Neuroimaging of Central Sensitivity Syndromes: Key Insights from the Scientific Literature.

Authors:  Brian Walitt; Marta Ceko; John L Gracely; Richard H Gracely
Journal:  Curr Rheumatol Rev       Date:  2016

Review 4.  The puzzle of fibromyalgia between central sensitization syndrome and small fiber neuropathy: a narrative review on neurophysiological and morphological evidence.

Authors:  Marina de Tommaso; Eleonora Vecchio; Maria Nolano
Journal:  Neurol Sci       Date:  2022-01-14       Impact factor: 3.307

5.  Efficacy of the use of two simultaneously TENS devices for fibromyalgia pain.

Authors:  Gabriela Rocha Lauretti; Eliana Fazuoli Chubaci; Anita Leocadia Mattos
Journal:  Rheumatol Int       Date:  2013-02-20       Impact factor: 2.631

Review 6.  [Postoperative pain therapy in Germany. Status quo].

Authors:  E M Pogatzki-Zahn; W Meissner
Journal:  Schmerz       Date:  2015-10       Impact factor: 1.107

7.  FMRI of spinal and supra-spinal correlates of temporal pain summation in fibromyalgia patients.

Authors:  Rachael L Bosma; Elham Ameli Mojarad; Lawrence Leung; Caroline Pukall; Roland Staud; Patrick W Stroman
Journal:  Hum Brain Mapp       Date:  2016-01-09       Impact factor: 5.038

Review 8.  Fibromyalgia: A Critical and Comprehensive Review.

Authors:  Andrea T Borchers; M Eric Gershwin
Journal:  Clin Rev Allergy Immunol       Date:  2015-10       Impact factor: 8.667

9.  Stress-induced allodynia--evidence of increased pain sensitivity in healthy humans and patients with chronic pain after experimentally induced psychosocial stress.

Authors:  Benjamin Crettaz; Martin Marziniak; Peter Willeke; Peter Young; Dirk Hellhammer; Astrid Stumpf; Markus Burgmer
Journal:  PLoS One       Date:  2013-08-07       Impact factor: 3.240

10.  Treatment of peripheral neuropathic pain by topical capsaicin: Impact of pre-existing pain in the QUEPP-study.

Authors:  C G Maihöfner; M-L S Heskamp
Journal:  Eur J Pain       Date:  2013-10-29       Impact factor: 3.931

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.